On day 7 after tumor challenge, a 3-fold increase in the frequency of H-2Kb/SIY+ CD8+ tumor infiltrating lymphocytes (TILs) was observed in IFNγR2- and Jak1-mutant tumors compared to WT tumors (Fig. 4b). The gene discussed is IFNGR2; the disease is neoplasm.